$3.000
-0.097 (-3.23%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Intensity Therapeutics Inc (INTS) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting INTS is Strong sell.
Intensity Therapeutics Inc (INTS) 20-Day simple moving average is 3.30, while Intensity Therapeutics Inc (INTS) share price is $—, making it Sell.
Intensity Therapeutics Inc (INTS) 60-Day simple moving average is 3.77, while Intensity Therapeutics Inc (INTS) share price is $—, making it Sell.
Technical Analysis for INTS
AI Technical INTSAs of 2026-11-07, the technical board for Intensity Therapeutics Inc (INTS) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $3.00 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 36.088, MACD stands at -0.114 (Sell), Stochastic %K stands at 50.428, Stochastic %D stands at 63.994 and CCI stands at -181.459 (Buy).
INTS trades below the 60-day SMA (3.77) and below the 200-day SMA (5.05). Immediate resistance sits at Classic R1 3.64, then R2 4.00. Support sits at Classic S1 2.87, then S2 2.45.
Intensity Therapeutics Inc (INTS) Support & Resistance Level
Intensity Therapeutics Inc (INTS) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 36.088 |
| STOCHk_14_3_3 | 50.428 |
| STOCHd_14_3_3 | 63.994 |
| CCI_20 | -181.459 |
| AO_5_34 | -0.210 |
| MOM_10 | -0.250 |
| MACD_12_26_9 | -0.114 |
Intensity Therapeutics Inc (INTS) Relative Strength Index (RSI_14) is 36.088, creating a Neutral signal.
Intensity Therapeutics Inc (INTS) Stochastic %K is 50.428, creating a Neutral signal.
Intensity Therapeutics Inc (INTS) Stochastic %D is 63.994, creating a Neutral signal.
Intensity Therapeutics Inc (INTS) CCI_20 is -181.459, creating a Buy signal.
Intensity Therapeutics Inc (INTS) Awesome Oscillator (AO) is -0.210, creating a Sell signal.
Intensity Therapeutics Inc (INTS) Momentum (MOM) is -0.250, creating a Sell signal.
Intensity Therapeutics Inc (INTS) Moving Average Convergence Divergence (MACD) is -0.114, creating a Sell signal.
Intensity Therapeutics Inc (INTS) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.282 | Sell |
| MA_10 | 3.291 | Sell |
| MA_20 | 3.304 | Sell |
| MA_60 | 3.770 | Sell |
| MA_200 | 5.053 | Sell |
| MA_250 | 6.172 | Sell |
Intensity Therapeutics Inc (INTS) 5-Day simple moving average is 3.282, while Intensity Therapeutics Inc (INTS) share price is $, making it a Sell.
Intensity Therapeutics Inc (INTS) 10-Day simple moving average is 3.291, while Intensity Therapeutics Inc (INTS) share price is $, making it a Sell.
Intensity Therapeutics Inc (INTS) 20-Day simple moving average is 3.304, while Intensity Therapeutics Inc (INTS) share price is $, making it a Sell.
Intensity Therapeutics Inc (INTS) 60-Day simple moving average is 3.770, while Intensity Therapeutics Inc (INTS) share price is $, making it a Sell.
Intensity Therapeutics Inc (INTS) 200-Day simple moving average is 5.053, while Intensity Therapeutics Inc (INTS) share price is $, making it a Sell.
Intensity Therapeutics Inc (INTS) 250-Day simple moving average is 6.172, while Intensity Therapeutics Inc (INTS) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.